Author

Andrzej Dymek

Observed names: A Dymek, A. Dymek

OpenAlex ID: A5020540789

Budesonide/Formoterol Maintenance Plus Reliever Therapy

2006 · Hans Bisgaard, Pascal Le Roux, et al. · CHEST Journal · 317

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

2011 · Anna Bodzenta-Lukaszyk, Andrzej Dymek, et al. · BMC Pulmonary Medicine · 74

PDF

Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler

2011 · Anna Bodzenta-Lukaszyk, Grażyna Pulka, et al. · Respiratory Medicine · 62

PDF

Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study

2012 · Paul K Keith, Andrzej Dymek, et al. · Primary Care Respiratory Journal · 26

PDF

Refluks krtaniowo-gardłowy (LPR) u pacjentów z przewlekłą chrypką

2012 · Andrzej Dymek, Lucyna Dymek, et al. · Otolaryngologia Polska · 12

P16 Fluticasone propionate/formoterol fumarate combination therapy has an efficacy and safety profile similar to that of its individual components administered concurrently: a randomised controlled trial

2010 · D. Bumbacea, A. Dymek, et al. · Thorax · 6

PDF

A new approach to studying the nasal and oral breathing routes

2013 · Andrzej Kukwa, Andrzej Dymek, et al. · Otolaryngologia Polska · 4

P177 Fluticasone propionate/formoterol fumarate combination therapy is as effective as fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial

2010 · A. Bodzenta-Lukaszyk, A. Dymek, et al. · Thorax · 2

PDF

P24 Fluticasone propionate/formoterol fumarate combination therapy has a more rapid onset of action than fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial

2010 · A. Bodzenta-Lukaszyk, A. Dymek, et al. · Thorax · 2

PDF

Malignant melanoma of the larynx.

1995 · Z Szudrowicz, A Dymek · PubMed · 2

Efficacy and Safety of Verekitug (UPB-101) in Chronic Rhinosinusitis With Nasal Polyps: Results of the Phase 2 VIBRANT Trial

2026 · Joseph Han, Piotr Skarzynski, et al. · Journal of Allergy and Clinical Immunology · 1

Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis

2011 · Paul Keith, Andrzej Dymek, et al. · Allergy Asthma and Clinical Immunology · 1

PDF

The presence of specific IgE to formaldehyde in patients with suspicion of hypersensitivity to this agent

2004 · A. Dymek, L. Dymek, et al. · Journal of Allergy and Clinical Immunology · 1

PDF

B32-17 Verekitug, a Thymic Stromal Lymphopoietin Receptor Antagonist, in Chronic Rhinosinusitis With Nasal Polyps: Effect on Type 2 Inflammatory Biomarkers in the VIBRANT Trial

2026 · S Sivapalasingam, J K Han, et al. · American Journal of Respiratory and Critical Care Medicine

B32-16 Verekitug, a Thymic Stromal Lymphopoietin Receptor Antagonist, Administered in Participants With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma in the Vibrant Trial

2026 · S Sivapalasingam, J K Han, et al. · American Journal of Respiratory and Critical Care Medicine

Technika oscylacji wymuszonych w praktyce alergologicznej i pulmonologicznej

2015 · Andrzej Dymek, Lucyna Dymek · Alergologia Polska - Polish Journal of Allergology

Laryngopharyngeal reflux - LPR in selected group from outpatient ENT clinic

2013 · Andrzej Dymek, Lucyna Dymek, et al. · European Respiratory Journal

Nutritional status of COPD patients with complete respiratory failure on long term home oxygen therapy

2012 · Dominika Posłuszna, Emilia M. Swietlik, et al. · European Respiratory Journal

The Association of Atopic Diseases with Hla Status

2006 · A. Bozek, J. Jarzab, et al. · Journal of Allergy and Clinical Immunology

[New computerized system for clinical evaluation of respiratory regulation].

1995 · A Koziorowski, L Radwan, et al. · PubMed

Works count: 20

Citation count: 510

H-index: 6

I10-index: 5